These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214 [TBL] [Abstract][Full Text] [Related]
23. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography. Dollé F J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model. Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506 [TBL] [Abstract][Full Text] [Related]
25. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. Iagaru A; Quon A; Johnson D; Gambhir SS; McDougall IR Mol Imaging Biol; 2007; 9(1):50-7. PubMed ID: 17051322 [TBL] [Abstract][Full Text] [Related]
26. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts]. Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor. Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610 [TBL] [Abstract][Full Text] [Related]
34. Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice. Wuest M; Hamann I; Bouvet V; Glubrecht D; Marshall A; Trayner B; Soueidan OM; Krys D; Wagner M; Cheeseman C; West F; Wuest F Mol Pharmacol; 2018 Feb; 93(2):79-89. PubMed ID: 29142019 [TBL] [Abstract][Full Text] [Related]
35. Functional Renal Imaging with 2-Deoxy-2- Werner RA; Wakabayashi H; Chen X; Hirano M; Shinaji T; Lapa C; Rowe SP; Javadi MS; Higuchi T J Nucl Med; 2018 May; 59(5):828-832. PubMed ID: 29242399 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS J Nucl Med; 2004 Dec; 45(12):2063-9. PubMed ID: 15585483 [TBL] [Abstract][Full Text] [Related]
37. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers. Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544 [TBL] [Abstract][Full Text] [Related]
38. An Automated Multidose Synthesis of the Potentiometric PET Probe 4-[ Waldmann CM; Gomez A; Marchis P; Bailey ST; Momcilovic M; Jones AE; Shackelford DB; Sadeghi S Mol Imaging Biol; 2018 Apr; 20(2):205-212. PubMed ID: 28905308 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET. Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565 [TBL] [Abstract][Full Text] [Related]
40. Retention of [(18)F]fluoride on reversed phase HPLC columns. Ory D; Van den Brande J; de Groot T; Serdons K; Bex M; Declercq L; Cleeren F; Ooms M; Van Laere K; Verbruggen A; Bormans G J Pharm Biomed Anal; 2015; 111():209-14. PubMed ID: 25898315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]